The CAB will lead and advise Genprex as it advances its REQORSA immunogen therapy program, including its Acclaim clinical trials in non-small cell lung...
College wheelchair tennis has grown significantly in recent years. Since 2019, the number of schools and athletes participating in the annual Collegiate Wheelchair...